A 58 Mb region on rat chromosome 4 known to regulate experimental autoimmune encephalomyelitis (EAE) was genetically dissected. High-resolution linkage analysis in an advanced intercross line (AIL) revealed four quantitative trait loci (QTLs), Eae24-Eae27. Both Eae24 and Eae25 regulated susceptibility and severity phenotypes, whereas Eae26 regulated severity and Eae27 regulated susceptibility. Analyses of the humoral immune response revealed that the levels of serum anti-myelin oligodendrocyte glycoprotein (MOG) immunoglobin G1 (IgG1) antibodies are linked to Eae24 and anti-MOG IgG2b antibodies are linked to both Eae24 and Eae26. We tested the parental DA strain and six recombinant congenic strains that include overlapping fragments of this region in MOG-EAE. Eae24 and Eae25 showed significant protection during the acute phase of EAE, whereas Eae25 and Eae26 significantly modified severity but not susceptibility. The smallest congenic fragment, which carries Eae25 alone, influenced both susceptibility and severity, and protected from the chronic phase of disease. These results support the multiple QTLs identified in the AIL. By demonstrating several QTLs comprising immune-related genes, which potentially interact, we provide a significant step toward elucidation of the polygenically regulated pathogenesis of MOG-EAE and possibly multiple sclerosis (MS), and opportunities for comparative genetics and testing in MS case-control cohorts.
Introduction
Multiple sclerosis (MS) is a common complex disease characterized by inflammation in the central nervous system with damage to myelin sheaths and nerve fibers. The genetic component of MS etiology has been shown by observations in twin cohorts and familial aggregation studies. [1] [2] [3] An influence from genes within the major histocompatibility complex (MHC) region is well established in MS and other inflammatory diseases, 4 and distinct regulation from non-MHC genes is only now emerging. 5 So far, only a few non-MHC genes have unambiguously been associated with MS, including IL2R and IL7R. [6] [7] [8] This is because of genetic heterogeneity, modest or weak effects of disease-predisposing genes, differences in environmental factors and use of cohorts of insufficient size. Identification of disease-regulatory genes may disclose disease pathways, new therapeutic targets and disease preventive strategies.
An approach to circumvent obstacles of gene identification in humans is to genetically dissect a rat model for MS, on the assumption that among species there are conserved mechanisms that lead to neuroinflammation. Close clinicopathological mimicry to human MS is important, and the model that best mimics MS with inflammatory infiltrates, prominent demyelination, axonal damage and a protracted relapsing disease course is myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in susceptible rat strains. 9, 10 Genome-wide linkage analyses performed in rat F2 crosses identified broad regulatory quantitative trait loci (QTLs) in EAE. [11] [12] [13] [14] In this study, we focus on a region of rat chromosome 4 (RN04) originally shown to regulate MOG-EAE severity and anti-MOG IgG2c antibody levels in an F2 cross between MHC identical EAE-susceptible DA and EAE-protected PVG.AV1 rats. 15 Subsequently, the genetic effect was confirmed in a congenic strain where the PVG alleles that overlap the region were transferred to DA rats through selective breeding. The congenic strain DA.PVG-C4R1 was found to have less severe MOG-EAE than the DA strain. 16 Interestingly, this 58 Mb region, which begins at 58.6 Mb on RN04, colocalizes with multiple QTLs for different inflammatory disease models identified in both crosses and congenic strains from several rat strain combinations ( Figure 1 ). The colocalization may reflect common genetic variations that predispose rats to different inflammatory diseases 17, 18 or influences from different genetic variations that are closely linked.
Our aim was to determine whether one or more genes within the 58 Mb region regulate EAE and to fine-map those genes. In this study, we used high-resolution QTL analysis in a previously described MOG-EAE experiment in the tenth generation (G10) of an advanced intercross line (AIL). [19] [20] [21] The present data reveal four distinct QTLs, Eae24-Eae27, that independently regulate and modify different MOG-EAE phenotypes and possibly interact to influence disease. The Eae25 confidence interval contains 42 genes in total, 20 of them with known functions (ensemble.org v. 49 ). These genes may be studied further both in classical hypothesis-driven research on neuroinflammation and in association studies of large MS case-control cohorts. This study reiterates that broad QTLs in a complex disease can be composed of several QTLs, as our data reveal four distinct QTLs.
Materials and methods

Advanced intercross line
The AIL from DA and MHC-identical PVG.AV1 rats 22 was established with two couples with DA as female founders and two couples with PVG.AV1 as female founders to obtain the F1 generation. Fourteen couples derived from the F1 generation, seven from each the DA and PVG female founders, created the F2 generation. The G3 generation originated from 50 breeding couples with both types of female founders. Random breeding of 50 males and 50 females, avoiding brother-sister mating, produced all subsequent generations. In the G10 generation, 794 rats were used from three similar sized litters for MOG-EAE experiments. [19] [20] [21] The DA and PVG.AV1 rats were originally obtained from Zentralinstitut for Versuchstierzucht (Hannover, Germany), and all the breeding was carried out at the Karolinska Hospital (Stockholm, Sweden) and Scanbur BK AB (Sollentuna, Sweden). The rats were housed in polystyrene cages containing aspen wood shavings under a 12 h light/dark cycle with free access to water and standard rodent chow. They were routinely monitored for specific pathogens according to a health-monitoring program for rats at the National Veterinary Institute (Uppsala, Sweden) according to FELASA criteria. Experiments were approved by the local ethical committee for North Stockholm.
Congenic strains
The congenic strains were established from DA and MHC-identical PVG.AV1 rats. The full-length DA.PVG-C4R1 congenic strain 23 was intercrossed with parental DA rats to create heterozygote rats that were bred to obtain recombinant strains with smaller homozygous PVG fragments. The following recombinant strains were tested in MOG-EAE: DA.PVG-(D4Rat23-D4Rat108) (R2), DA.PVG-(D4Rat23-D4Mit12) (R3), DA.PVG-(D4Rat103-D4Mit12) (R11), DA.PVG-(D4Rat231-D4Mit12) (R13), DA.PVG-(OT40.07-D4Mit12) (R21), and DA.PVG-(D4Got64) (R23) (Figure 2 ). In total, six MOG-EAE experiments were completed using female rats.
Induction and determination of disease phenotypes
Recombinant rat MOG, amino acids 1-125 from the N terminus, was expressed in Escherichia colii and purified to homogeneity by chelate chromatography. 24 Rats were immunized with a 200 ml subcutaneous injection, at the dorsal tail base, under anesthesia with isoflurane (Abbott Laboratories, Abbott Park, IL, USA). Each inoculum contained 20 mg (for AIL experiments) and 13-85 mg (for congenic experiments) of recombinant rat MOG emulsified in saline with incomplete Freund's adjuvant (Sigma Aldrich, St Louis, MO, USA), in 1:1 ratio.
Signs of EAE and body weight were monitored daily from day 9 until days 28-40 after immunization, when the animals were killed with CO 2 . The scale for EAE scoring was as follows: 0, healthy; 1, tail weakness Figure 1 A 58 Mb region on rat chromosome 4 that contains many quantitative trait loci (QTLs) regulating rat experimental inflammatory diseases. The black vertical bar represents rat chromosome 4 (RN04). The gray vertical bar represents the region of interest in this paper (ROI). Rat QTLs that regulate experimental models for inflammatory diseases are depicted on the side of the vertical bar. 15, 23, [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] Linkage to experimental autoimmune encephalomyelitis (EAE) over this region was shown in an F2 (DA Â PVG.AV1) intercross, 15 indicated by gray vertical bar, with survival linked to PTRY24 and IgG2c anti-MOG antibody levels linked to D4Mit12, with no QTL name attributed. QTLs depicted location and characteristics are based on data from RGD (http://rgd.mcw.edu/ August 2008) and Ensembl genome database (http://www.ensembl. org v.50).
or tail paralysis; 2, hind leg paresis or hemiparesis; 3, hind leg paralysis or hemiparalysis; 4, tetraplegy; and 5, moribund state or death. If severe disease (score 4) was observed for 2 consecutive days, the rats were killed. To prevent a reduction in power of the statistical analysis, killed rats were included in the scoring with an EAE score of 4. The following clinical parameters were assessed: incidence of EAE, that is, signs of EAE present for more than 1 day; onset of EAE, that is, day of first clinical sign; duration of EAE, that is, the number of days rats showed clinical signs; maximum EAE score and cumulative EAE score, that is, sum of the EAE scores obtained from day 9 until the end of experiment. Blood was collected from rats in the AIL Figure 2 Four distinct experimental autoimmune encephalomyelitis (EAE)-regulating quantitative trait loci (QTLs) on rat chromosome 4, Eae24-Eae27. Log-likelihood plots of the EAE-regulating QTLs, Eae24-Eae27, in the region spanning from 58 to 116 Mb. The microsatellite markers are depicted on the x axis and the distance between them reflects the recombination fraction in our experimental population rather than physical location. Peak markers corresponding to each QTL are written in bold and are as follows: D4Rat26 for Eae24, D4Got64 for Eae25, D4Rat38 for Eae26 and D4Rat233 for Eae27. Thick black horizontal bars above the x axis indicate the confidence intervals of Eae24-Eae27 according to a 1.5 LOD support interval. Phenotype abbreviations: INC, incidence of EAE; MAX, maximum EAE score; CUM, cumulative EAE score; WL, weight loss; IgG1, anti-MOG IgG1 serum level; IgG2b, anti-MOG IgG2b serum level. The chosen phenotypes are representative of EAE susceptibility (that is INC), EAE severity (that is, MAX and CUM), a continuous trait that follows the course of EAE (that is, WL) and the anti-MOG antibody response (that is, IgG1 and IgG2b). Gray horizontal bars below the x axis indicate the regions where PVG alleles are introgressed into a DA background in recombinant congenic strains tested in MOG-EAE. The following recombinant strains were tested in MOG-EAE: DA.PVG-(D4Rat23-D4Rat108) (R2, Eae24 and Eae25), DA.PVG-(D4Rat23-D4Mit12) (R3, Eae24, Eae25, Eae26 and part of Eae27), DA.PVG-(D4Rat103-D4Mit12) (R11, Eae26 and part of Eae27), DA.PVG-(D4Rat231-D4Mit12) (R13, Eae26 and part of Eae27), DA.PVG-(OT40.07-D4Mit12) (R21, Eae25, Eae26 and part of Eae27) and DA.PVG-(D4Got64) (R23, Eae25).
experiments on day 14 after immunization for evaluation of anti-MOG antibody levels. Loss of weight is a subphenotype of EAE, 25 which may depend on inflammation-mediated effects or the inability to hydrate and eat properly. Weight loss (in AIL defined as (weight at day 8 after immunization-minimum weight during the experiment)/weight on day 8 after immunization), reflects subclinical disease and is a quantitative trait considered to correlate well with EAE disease course.
Anti-MOG isotype determination
Anti-MOG antibody levels in sera were measured by enzyme-linked immunosorbent assay. Ninety-six-well enzyme-linked immunosorbent assay plates (Nunc, Roskilde, Denmark) were coated with 10 mg ml À1 of recombinant rat MOG (100 ml per well) overnight at 4 1C. Plates were washed with phosphate-buffered saline/0.05% Tween 20 and free binding sites were blocked with 5% fat-free milk in phosphate-buffered saline/0.05% Tween 20 for 1 h at room temperature. After washing, diluted serum samples were added and incubated for 1 h at room temperature. Rabbit anti-rat immunoglobin G1 (IgG1) (1:1000) or IgG2b (1:2000) (Nordic, Tilburg, Netherlands) were added for 1 h at room temperature after washing. Unbound antibodies were removed by washing before addition of a peroxidase-conjugated goat anti-rabbit antiserum (Nordic) (1:10000). After 30 min incubation, plates were washed and bound antibodies were visualized with 3,3 0 ,5,5 0 -tetramethylbenzidine (Sigma Aldrich). The reaction was stopped by addition of 1 M HCl after 15 min incubation in darkness and the optical density was read at 450 nm. Serum samples from rats with high levels of each isotype detected in a pilot study were included on each plate to create a standard curve.
Genotype analysis DNA was extracted from the tail/ear tip of 794 G10 AIL rats and every rat bred for development of the congenic strains. 26 Genotyping was performed using 33 PCR primer pairs for microsatellites (Proligo, Paris, France) in the DNA samples, with D4Rat23 and D4Mgh17 at the extremities of the 58 Mb region analyzed. The same markers, or closely located ones, were used during the breeding of congenic strains. Microsatellite markers physical positions were obtained from Ensembl genome database v. 31 P]ATP end-labelling of the forward primer was carried out, and products were size fractionated in 6% polyacrylamide gels and visualized by autoradiography. All genotypes were evaluated manually at two occasions by different observers and scrutinized at the positions where errors were inferred by R/qtl analysis.
Statistical analyses
For the AIL data, the multiple imputation method 28 implemented in the R/qtl statistical software 29 allowed us to perform interval mapping to identify the QTLs of main effect, two-dimensional scans with a two QTL model and fit multiple QTL model tests. The twodimensional scans with a two QTL model examine all pairs of markers and intermarker positions for association with a given phenotype, to identify additive effects and epistatic interactions between the loci. The fit multiple QTL modeling allows the statistical validation of the independent effect of each identified QTL and its interactions. It does so by subtracting the effect of each QTL or QTL interaction and comparing that model to the initial model of phenotypic variance where all QTLs have a full effect. The imputation method was chosen as it could be used with multiple interacting QTLs, multivariate and non-normally distributed phenotypes, covariates, missing genotype data and genotyping errors in inbred line crosses. The conventional permutation method 30 could not be used to set the significance thresholds due to the different family structure of the G10 compared with F2 generations for which it is developed. To set the significance threshold, we computed the mean for each family and the residual value from the family mean for each rat and repeated the oneand two-dimensional scans in the residual data set (indicated in parenthesis in applicable tables). In addition, the maximum LOD scores for the original onedimensional scan were all higher than 3.4. 31 We defined confidence intervals as a 1.5 LOD support interval from the QTL peak location 32 and defined the limits as the location of the closest genotyped marker outside the interval. Kruskal-Wallis ranking test (JMP, version 4.0.2, SAS Institute, Cary, NC, USA) was used to confirm the influence of peak markers defined in the linkage analysis.
Probability for each QTL was calculated using a bootstrap approach. Simulated pedigrees were sampled with replacement from the observed AIL individuals to create a new data set with the same number of samples (794), which was mapped using a single-QTL model in R/qtl. This model was used because a multiple QTL model makes Eae24 and Eae26 compete with each other for effect in concert with Eae25, whereas a single-QTL model forces each QTL to independently compete for effect. The maximum LOD and the location of that maximum were recorded and the resampling was repeated 1000 times to obtain an estimate of the probability of a QTL being present within the confidence interval of each QTL. This procedure was repeated for each phenotype.
To analyze the experiments with congenic strains, each strain was compared with parental DA. Onset of EAE, duration of EAE, maximum and cumulative EAE score were analyzed using the Mann-Whitney U-test and Fisher's exact test was used to compare the incidence of EAE. All calculations were carried out using the PC versions of JMP 6.0.0 (SAS Institute); P-values p0.05 were considered significant. In addition, data were normalized to each experiment and pooled for a combined analysis. The normalization was carried out by subtracting the experiment average phenotype score from each individual's score and then dividing the residual by the experiment standard deviation (s.d.). To ensure that the variation in days of observation between experiments did not confound the results, the experiments were adjusted to include only days scored in all experiments. There was no difference in results between the normalized data and the data adjusted before it was normalized, and the results presented here are based on the normalized but not adjusted sample. Each congenic strain was compared with parental DA, and only DA rats from the experiments including each particular strain were used for the comparison.
Results
Identification of Eae24-Eae27, four distinct EAE-regulating QTLs in the 58 Mb region We resolved the 58 Mb region into four distinct EAE QTLs, Eae24-Eae27 by linkage analysis in the tenth generation of the AIL ( Figure 2 ). All four QTLs were statistically significant, with LOD scores greater than the values obtained for the maximum LOD score of the family residual data in each phenotype and also greater than 3.4 theoretical LOD threshold. 31 When analyzing the allelic effect of each QTL individually, rats homozygous for DA alleles were predisposed to EAE (that is, displayed earlier onset of EAE, longer duration of EAE and higher incidence of EAE, maximum EAE score and cumulative EAE score) when compared with heterozygous rats or rats homozygous for PVG alleles (data not shown). There was a sex difference in the incidence of EAE, with 36% (n ¼ 150) affected females and 20% (n ¼ 73) affected males. Therefore, the regression model used for linkage analysis included sex as an interactive covariate. In addition, family of origin was included as a covariate in the model to adjust for the family structure of the G10.
Distinct sets of QTLs within Eae24-Eae27 co-segregate with EAE susceptibility or severity Hypothetically, susceptibility to complex genetic disorders can be determined by an accumulation of genetic factors with weak to modest effects. Synergistic effects of these susceptibility genes in concert with environmental factors may precipitate an autoimmune disease. The phenotypes capturing susceptibility in our disease model, incidence and onset of EAE, may be consistent with such hypothesis. Eae24, Eae25 and Eae27 were linked to susceptibility phenotypes, with confidence intervals size spanning B12.2, B4 and B9.6 Mb, respectively, according to the physical map (Table 1, Figure 2 ). EAE severity phenotypes (maximum EAE score, cumulative EAE score and duration of EAE) were linked to Eae24, Eae25 and Eae26. Eae24 and Eae25 coincided with the intervals defined by susceptibility phenotypes, whereas the confidence interval for Eae26 spanned B15.9 Mb region for maximum EAE score and cumulative EAE score and B10.9 Mb for duration of EAE (Table 2, Figure 2 ). To ensure that linkage of severity phenotypes was not influenced by underlying susceptibility, the analysis was repeated on the subset of animals that showed signs of EAE (INC ¼ 1, n ¼ 226). As expected, severity remained linked to Eae24, Eae25 and Eae26. Although there was a slight shift in peak markers, there were no differences in the confidence intervals compared with the full set (Supplementary Table 1) . Weight loss, which might reflect subclinical disease, was associated with Eae25 and Eae26. Although maintaining the same peak markers, the confidence interval for Eae26 was considerably narrower, B2.9 Mb for weight loss compared with 10.9-15.9 Mb for severity phenotypes. Thus, Eae26 regulates severity phenotypes and weight loss, but does not regulate susceptibility phenotypes. In contrast, Eae27 regulates only susceptibility phenotypes and not severity.
Anti-MOG antibody levels for IgG1 and IgG2b are linked to Eae24 and Eae26
In most MS patients, lesions in the central nervous system contain Ig deposits. [33] [34] [35] Further, MOG-specific antibodies localize in areas of disintegrating myelin within EAE lesions 36 and circulating anti-MOG antibodies exacerbate clinical impairment and demyelination. 37 We measured the levels of anti-MOG antibodies at day 14 after immunization, the approximate time of disease onset. To approximate a normal distribution, the data were transformed by taking the square root of each individual's phenotype score. Of the four QTLs, only Eae24 showed linkage to both anti-MOG antibody isotypes tested. The linkage was significant for IgG1 (LOD ¼ 4.9) and IgG2b (LOD ¼ 3.9) with confidence intervals of B20 and B13 Mb, respectively (Table 3, Figure 2 ). In addition, IgG2b was also linked to Eae26 (LOD ¼ 5.8).
Probability of the influence of Eae24-Eae27 on EAE To estimate the probability for each QTL independently contributing to EAE phenotypes, we sampled simulated pedigrees with replacement from the observed individuals. d Percent probabilities were generated by simulating 1000 pedigrees sampled with replacement from the observed individuals, and each was mapped using a single-QTL model with imputation method in R/qtl. Probability was calculated as the percentage of times the maximum LOD was located within the confidence interval of each QTL.
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A single-QTL model was used to force all QTLs to compete for effect. This model was selected because a multiple QTL model makes only either Eae24 or Eae26 map together with Eae25, wheras Eae25 and Eae27 are independent of the other QTLs. To overcome this problem, which is likely due to the QTLs being closely linked, a single-QTL model was used. To obtain the probability of a QTL being present within the confidence interval of each QTL, the percentage of times the maximum LOD score was placed within the confidence interval of each QTL was used (Tables 1-3) . Consistent with the linkage analysis, different sets of QTLs are probable to influence susceptibility and severity phenotypes ( Figure 3 ). Susceptibility phenotypes have higher probability of being influenced by Eae27 ( Figures  3a and b) , whereas severity phenotypes have a higher probability of being influenced by Eae26 (Figures 3c,  d and e). Eae24 and Eae25 influence both sets of phenotypes, but with a more modest probability (Figures 3a-f) . The probability analysis also supports that Eae24 influences both IgG1 (Figures 3a and h ) and IgG2b (Figure 3h ), and Eae26 also influences IgG2b.
Recombinant congenic strains show that Eae24-Eae27 modify EAE phenotypes in a complex manner
We used congenic mapping and tested six recombinant congenic strains in MOG-EAE. Commonly, the parental DA strain displays a relapsing-remitting disease course with an average onset of EAE around 2 weeks after immunization, while the parental PVG.AV1 is resistant to a similar induction protocol. EAE phenotypes such as incidence of EAE, onset of EAE, maximum and cumulative EAE scores and duration of EAE were evaluated for each strain. When each of the six experiments was analyzed separately, there were no differences in susceptibility or severity between R2, R3, R11 and R13 compared with DA. However, R2, which bears both Eae24 and Eae25, showed significant protection during the first bout of EAE (Figure 4d ). R21, which bears Eae25, Eae26 and part of Eae27, significantly modified severity phenotypes but showed no difference in susceptibility (Table 4 , Figure 4) , with lower maximum EAE score and cumulative score, and a later onset of EAE. In addition, R21 was protected throughout the first and second bout of EAE (Figure 4e ), despite there being no differences in incidence. In addition, R23, which bears Eae25, influenced both susceptibility and severity (Table 4 , Figure 4) , with a lower incidence and later onset of EAE, lower maximum EAE score and cumulative score, and a later onset of EAE. R23 was also protected from the second bout of disease (Figure 4f ). Percent probabilities were generated by simulating 1000 pedigrees sampled with replacement from the observed individuals, and each was mapped using a single-QTL model with imputation method in R/qtl. Probability was calculated as the percentage of times the maximum LOD was located within the confidence interval of each QTL. Percent probabilities were generated by simulating 1000 pedigrees sampled with replacement from the observed individuals, and each was mapped using a single-QTL model with imputation method in R/qtl. Probability was calculated as the percentage of times the maximum LOD was located within the confidence interval of each QTL.
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To increase the power of the analysis, a combined analysis was performed on normalized and pooled data. There were no differences in susceptibility between R2, R11 and R21 compared with DA ( Figure 4a , Table 5 ). However, severity was influenced by the congenic fragments in R2 (Eae24 and Eae25), R11 (Eae26 and part of Eae27) and R21 (Eae25, Eae26 and part of Eae27) (Figures 4b and c, Table 5 ). As expected from the previous analysis, R23 (Eae25) influenced both susceptibility and severity (Figures 4a, b and c, Table 5 ). There were no differences in susceptibility and severity between R3 and R13 compared with DA.
R3 carries the entire PVG fragment that is included in the other recombinant strains (Eae24, Eae25, Eae26 and part of Eae27) but did not show any differences in EAE phenotypes when compared with DA. Although an influence on EAE could be shown in the smaller R2 and R11 regions, which together compose the R3 region, the PVG alleles in the entire fragment weakened the protective effect. This indicates a possible interaction Figure 4 Recombinant congenic strains confirm influence of Eae24, Eae25, Eae26 and Eae27 on experimental autoimmune encephalomyelitis (EAE) susceptibility and severity. EAE susceptibility and severity phenotypes in congenic strains show that congenic strains with PVG alleles in R2 (Eae24 and Eae25), R11 (Eae26 and part of Eae27), R21 (Eae25, Eae26 and part of Eae27) and R23 (Eae25) are protected from EAE, whereas congenic strains with PVG alleles in R3 (Eae24, Eae25, Eae26 and part of Eae27) and R13 (Eae26 and part of Eae27) are not. Phenotype abbreviations: INC, incidence of EAE; MAX, maximum EAE score and CUM, cumulative EAE score. (a-c) Data were collected from six experiments, normalized to each experiment ((individual phenotype scoreÀexperiment mean phenotype score)/experiment s.d.) and pooled. The normalized values are depicted here, with negative values representing protection and positive values representing exacerbation (from the experiment means). Each strain was compared with parental DA. DA, n ¼ 141; R2, n ¼ 32; R3, n ¼ 37; R11, n ¼ 28; R13, n ¼ 35; R21, n ¼ 35; and R23, n ¼ 41. (a) Fisher's exact test was used to compare the incidence of EAE. The statistical comparison was carried out using DA rats from the experiments that each strain participated in (Table 4) 
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QTLs display epistatic interactions
Interactions of immunoregulatory genes have been suggested to have an important funtion in autoimmunity. 38 These interactions can result from specific combinations of alleles at multiple loci that amplify or abrogate the independent gene effects. Such interactions have been demonstrated in autoimmune-related systems, such as with the genes encoding SLAM/CD2 receptor family, 39 Fas(lpr)/Lmb3, 40 Ig GM and interleukin (IL)-6. 41 In our analysis of the AIL, an epistatic interaction was detected between Eae24 and Eae25 for both susceptibility and severity ( Figure 5 ). In addition, an additive interaction that affected severity phenotypes was found between Eae24 and Eae27 (Table 6, Figure 5 ). For all pairs of positions that showed interaction, interaction plots were used to investigate the allelic effects involved and to depict how the EAE phenotypes were modified by specific allele combinations. As expected, PVG alleles generally showed protection, whereas DA alleles aggravated EAE.
For the epistatic interaction between Eae24 and Eae25, rats that were homozygous DA at either Eae24 or Eae25, while heterozygous at the other locus displayed increased disease susceptibility compared with the rats that had the other allele combinations, 50 and 43%, respectively, had EAE compared with 24% in any other allele combinations together (Figure 5c ). Furthermore, rats that were heterozygous at Eae24 and homozygous PVG at Eae25 were protected from EAE, with 13% incidence. For the interaction between Eae24 and Eae27, rats that were PVG homozygous at both loci were, as expected, protected from EAE with 15% incidence. In addition, rats that were heterozygous at Eae24 and heterozygous or homozygous PVG at Eae27 had lower susceptibility and severity, 16 and 7% of them displaying EAE, respectively, compared with 35% in the other allele combinations. The values reported above were obtained from the analyses on incidence of EAE; the other phenotypes were analyzed in a similar manner and granted results with similar conclusions (data not shown).
To determine the influence of all identified QTLs and interactions, we used a fit multiple QTL model (R/qtl). 29 When comparing the y BEae24 þ Eae25 þ Eae26 þ Eae27 þ Eae24:Eae25 þ Eae24:Eae27 model with a model in which Eae24, Eae25, or Eae27 were excluded, a major influence of each QTL was demonstrated for susceptibility phenotypes (Figure 5b) . Furthermore, excluding the interactions between Eae24 and Eae25 and the interactions between Eae24 and Eae27 revealed an influence of these interactions on both incidence of EAE and onset of EAE. Thus, the fit multiple QTL model analyses confirmed that Eae24, Eae25, Eae27 and the Strains R2 and R21were monitored for 31 days, whereas R23 was monitored for 38 days. DA scores for both periods are included, and these were used respectively in the comparisons. Investigation of AIL mapping data is consistent with congenic strain data To estimate the influence of allele combinations on disease characteristics of the recombinant congenic strains, the effects identified in the AIL were used to calculate the expected phenotype values for each strain ( Table 7 ). Considering that each QTL is likely to contribute with small effects to the overall EAE phenotype, while the interactions contribute with more than only the additive effect, an increased number of protective allele combinations would be expected to result in greater protection from EAE. It is also most important to note that no heterozygous states were represented in the congenic strains in contrast to the AIL. Protective PVG alleles overlapping Eae24 and Eae25 are represented in R2 and R3 together with the permissive interactive combination Eae24-PVG Â Eae27-DA. As these effects could partly abrogate each other, these strains were expected to show a modest effect compared with the other recombinant strains. In the experiment, R2 showed significant protection during the acute phase of EAE and reduced severity, whereas R3 showed similar tendencies but did not show significant differences, when compared with DA. Recombinant strains R11 and R13 carry the protective PVG alleles from Eae26 only (Eae26 regulates severity) and are no different than the DA parental in either interaction combination (Eae24-DA Â Eae25-DA and Eae24-DA Â Eae27-DA). These strains were therefore also expected to show a more modest effect and only on severity phenotypes. In the congenic experiments, R11 showed significantly reduced severity, whereas R13 did not show any differences. Protective PVG alleles in Eae25 are carried by R21 and R23 together with the protective combination Eae24-DA Â Eae25-PVG, which is expected to influence EAE susceptibility. These strains were hence expected to show a stronger protective effect than the other recombinant strains, which is consistent with the results from the congenic experiments. Indeed, PVG alleles in R23 influenced both susceptibility and severity in the congenic experiments and protected during the late phase of EAE. In addition, R21 carries protective PVG alleles from Eae26, which is expected to modify EAE severity without affecting susceptibility, and R21 showed attenuated disease with protection during the acute and chronic phase of EAE in the experiments. Our data show that the 58 Mb region on rat chromosome 4 is composed of four distinct QTLs, Eae24-Eae27. Each of these QTLs is likely to contain at least one gene that regulates MOG-EAE. A set of these genes is involved in the regulation of EAE susceptibility, whereas other genes primarily regulate EAE severity once disease has ensued. Furthermore, several genes underlying different combinations of QTLs regulate EAE susceptibility or severity through interactions. Our results constitute important progress toward understanding the complexity of EAE-regulating QTLs identified in large resolution population and their functional interactions. Fisher's exact test, using the DA controls only from experiments that included the specific strain compared. Mann-Whitney U-test. Figure 5 Epistatic interaction between Eae24 and Eae25 modifies experimental autoimmune encephalomyelitis (EAE) susceptibility and severity. (a) The pairscan for incidence of EAE is shown as a representative for all clinical phenotypes. A significant difference in the phenotypic variance defines an independent quantitative trait loci (QTL). The epistatic interaction between Eae24 and Eae25 is indicated in bright red in the upper triangle and also in the lower triangle. The additive interaction between Eae24 and Eae27 is indicated in bright red in the lower triangle. The arrow between Eae24 and Eae25 indicates the epistatic interaction and the arrow between Eae24 and Eae27 indicates the additive interaction. The significance thresholds are the maximum LOD scores obtained from the analysis of residual values from the family mean for each phenotype. (b) The positions used in the fit multiple QTL model were the following: Eae24 for D4Rat26, Eae25 for OT40.07, Eae26 for D4Rat37 and Eae27 for D4Rat233. For Eae25 the original QTL peak location at D4Got64 was replaced by the position for epistatic interaction identified in the pairscan analysis. Eae24:Eae25 and Eae24:Eae27 represent the effect of the interactions to be excluded from the model, whereas the effect of single QTLs are kept. (c) The allelic effect plots illustrate the influence of the interacting loci on incidence of EAE and the difference between epistatic and additive interactions. Eae24 genotype groups at peak marker D4Rat26 are color-coded according to genotype at this locus. Eae25 is represented by marker OT40.07, indicated on the x axis. Eae27 is represented by marker D4Rat233, indicated on the x axis.
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Discussion
Our study represents an example of a broad EAE QTL originally identified in an F2 cross or by substitution mapping, which contains more than one regulatory gene. 19, 22 Three categories of QTLs were revealed: Eae27 is only linked to susceptibility phenotypes, Eae26 is only linked to severity phenotypes and Eae24 and Eae25 are EAE-regulating QTLs on RN04 M Marta et al linked to both. Hypothetically, polymorphisms within genes in these QTLs may cause an individual to pass the threshold to develop EAE, weaken resistance to the immune attack or shorten the time required to develop EAE. Furthermore, Eae24, Eae25 and Eae26 showed linkage to severity phenotypes. These QTLs possibly regulate the severity of the EAE attack, chronic nature of the symptoms and disease course, but may also influence the recovery mechanisms either in the immune system or the target organ. 42 Moreover, our analysis also presented evidence for additive and epistatic interactions in EAE regulation. Susceptibility and severity were influenced by an epistatic interaction between Eae24 and Eae25, while susceptibility was affected by an additive interaction between Eae24 and Eae27. It is important to note that phenotypic variance of the AIL also depends on other genome regions [19] [20] [21] 43 and the QTLs identified here can be influenced by QTLs located in other parts of the genome.
We used interval-specific recombinant congenic strains to test the influence of fragments in the C4R1 region on MOG-EAE. These experiments confirmed the existence of multiple QTLs within the region and show that each QTL has an influence on EAE. When analyzing the allelic effect of each QTL individually, rats homozygous for DA alleles were predisposed to EAE (that is, displayed earlier onset of EAE, longer duration of EAE and higher incidence of EAE, maximum EAE score and cumulative EAE score) when compared with rats heterozygous or homozygous for PVG alleles. However, when considering the combined effect of all four QTLs, the allele combinations in the region are more important than individual effects. Furthermore, each QTL modified different aspects of disease. PVG alleles in R23 (which bears Eae25) influenced both susceptibility and severity phenotypes and were protective during the late phase of EAE, whereas PVG alleles in R2 (which bears both Eae24 and Eae25) were protective during the acute phase of disease. PVG alleles in R21 (which bears Eae25, Eae26 and part of Eae27) were protective throughout the disease course, despite there being no differences in incidence. 
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This indicates that these QTLs contain genes that modify EAE symptoms once disease has ensued. R23 (Eae25) was the only recombinant congenic strain capturing a single QTL, and therefore Eae25 was the only QTL we could study in isolation. As expected from the AIL analysis, Eae25 influenced both susceptibility and severity. Furthermore, only severity was influenced by the PVG alleles in R2 (Eae24 and Eae25) and R11 (Eae26 and part of Eae27). Because Eae24 and Eae25 influence both susceptibility and severity, it may be difficult to distinguish between the phenotype groups in congenic strains containing both QTLs. The QTLs with distinct influence on susceptibility or severity, Eae27 and Eae26, respectively, were not split in any of the congenic strains tested; therefore the effects of each in isolation could not be evaluated. However, it was expected that the congenic strains with PVG alleles including both QTLs (R3, R11, R13 and R21) would show an influence on both phenotype groups, but only severity was significantly affected.
Interactions that amplify or abrogate the independent gene effects further complicate the interpretation of effects in the interval-specific recombinant strains. For the additive interaction between Eae24 and Eae27, R2 and R3 strains carried a permissive allele combination that abrogated the effect from the protective PVG alleles in Eae24 and Eae25. Equally important, R21 and R23 strains carried a protective allele combination for the epistatic interaction between Eae24 and Eae25 that amplified the protective effect from the PVG alleles in Eae25. R3 strain carried the entire PVG fragment that was divided in the other recombinant strains (Eae24, Eae25, Eae26 and part of Eae27) but did not show significant differences in EAE phenotypes when compared with DA, although an influence on EAE could be shown from the smaller PVG fragments in R2 and R11. One possible explanation could be an extension of the PVG fragment in R3 in a 3 Mb region in Eae27 (D4Rat232-D4Rat233), where no polymorphic markers could be found. Nonetheless, the congenic data further support that the region we have dissected here contains multiple QTLs and complex interactions. Furthermore, it cannot be excluded that other loci in the genome also interact with the genes in Eae24-Eae27.
Dissection of the effects of closely linked QTLs in a structured population, such as the AIL, presents a number of analytical challenges as most analysis approaches are constructed to test a locus singled out from the background. This 58 Mb region probably represents a more realistic situation, where genes regulating similar phenotypes are physically close. To account for the family structure, the family of origin was included as a covariate in the model used for linkage and interaction analyses. Furthermore, significance thresholds were set using data controlling for the within family variance (individuals' residual from the family mean). To test the robustness of the identified QTLs, we calculated the probability of each QTL in simulated pedigrees sampled from the observed individuals. To test the effect of each QTL, despite the fact that they are linked, and simplify the interactions, we used a single-QTL model. Because the four QTLs were forced to compete for effect, an average probability expected (assuming equal effect, which is not necessarily the case) would be no greater than 25% per QTL as opposed to 100% in a single-QTL region. It is therefore not surprising that some probabilities are as low as 5%, which corresponds to 20%, a commonly used cutoff, in a single-QTL region.
The existence of at least four EAE-regulating genes and the evidence for the epistatic interactions supports the concept that functionally related genes are located in the vicinity of each other, as is well known for genes in the MHC region. However, it is also possible that the QTL was originally detected because of an accumulation of genes with modest or weak effects, and without any functional relationship. In any case, EAE susceptibility and severity are clearly affected by multiple genes, and genes that interact, a concept that should be addressed in the genetic analysis of human complex diseases.
Resolution to a small number of candidate genes, which enables rapid identification of EAE-regulatory genes, was achieved, as in the case of 20 genes contained in Eae25. The other QTLs contained more genes, with several extremely interesting candidates based on their effects in EAE and MS. These candidate genes can be tested in association studies of large MS case-control cohorts in parallel with functional studies carried out in an experimental setting. For example, the T-cell receptor Vb (TCRBV) cluster, located in Eae24, has long been studied and targeted in MS and EAE. There are conflicting data on the possible genetic association of TCRBV genes in MS, where more recent studies could not reproduce evidence for linkage. 44 Our results set the stage to investigate if and how polymorphisms of TCRBV genes affect an autoimmune disease such as MOG-EAE. If indeed TCRBV genes are relevant for the regulation of the anti-MOG antibody response, polymorphisms in these genes could be of importance in the T-cell receptor recognition of MOG peptides presented by the MHC, which in turn may affect the recruitment of anti-MOG autoagressive responses and the T-cell engagement needed to mount the humoral response.
Interestingly, Src family associated phosphoprotein 2 (Scap2) mapped to Eae25. Scap2 is known to influence B-cell function in EAE. 45 Another member of this gene family affects T-cell activation initiated through the T-cell receptor, regulated by SRC homology 2 domain-containing protein tyrosine phosphatase 1 (SHP-1). This process influences EAE. 46 The known roles of TCRBV and Src family genes are consistent with the epistatic interaction between Eae24 and Eae25 we observed, hypothetically involving the same pathway of lymphoid cell activation. Neuropeptide Y is a further potential candidate within Eae25, which ameliorates symptoms of EAE. 47 In the case of Eae26, there are some interesting candidates in the interval such as Ig kappa light-chain genes. Elevated values of kappa light chains in the cerebrospinal fluid are proposed to correlate with disability in MS. 48 Perhaps even more attractive candidates, for the central role in EAE pathogenesis, are the genes that encode IL-12 receptor-b 2 49 and IL-23 receptor, 50 which mapped to Eae26. Interestingly, polymorphic variants of IL-23 receptor were recently shown to be associated with inflammatory bowel disease 51 but did not show association in MS. 52 This study provides an example of distinct EAE QTLs with linkage to an immunological subphenotype. The data reveal that Eae24 and Eae26 regulate the anti-MOG antibody response. We consider two principal ways in which genes in these QTLs could regulate disease: (1) by EAE-regulating QTLs on RN04 M Marta et al enhancing anti-MOG antibody production, which would directly exacerbate disease; or (2) the antibody levels could reflect the intensity of the T-cell response to MOG, which would represent a direct link to disease regulation. These possibilities are not mutually exclusive. Moreover, anti-MOG antibodies directed against conformational epitopes have been shown to mediate antibody-mediated demyelination; 53, 54 thus, being consistent with the first option. It is generally accepted that the IgG isotype profile reflects the underlying cytokine environment in EAE. In rat, more specifically, IgG1 levels reflect the T2-type immune response, whereas IgG2b levels reflect the T1-type immune response under specific circumstances. 55, 56 Accordingly, our results would suggest that Eae24 regulates a general anti-MOG T-cell helper response, whereas Eae26 regulates a T1-biased immune response and may have a weaker regulatory effect on a T2-type response in EAE. Further aspects of the cytokine profile regulated by Eae24 remain to be studied, such as the IL-23/IL-17 pathway effects on EAE.
This supports our strategy of identification of genes in experimental systems that may prove relevant for human disease. The genes within Eae24-Eae27 include interesting candidates for regulation of inflammatory diseases. These candidates will be the focus of functional studies of immune mechanisms in parallel with association studies using large cohorts of patients and healthy controls. In this study, we show an approach combining high-resolution mapping using an AIL, together with substitution mapping, to better understand the influence of this gene-rich EAE-regulating genome region. Further studies on identified genes will lead to an increased understanding and will help elucidate EAE and MS pathogenesis.
